Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort

Madonia, S ; Calvaruso, V ; Filomia, R ; Cannavò, M.R ; Di Stefano, M ; Russello, M ; Davì, A ; Scifo, G ; Volpes, R ; Montineri, A ; Ficalora, R ; Malizia, G ; Digiacomo, A ; Bertino, G ; Alaimo, G ; Licata, A ; Cacopardo, B ; Averna, A ; Guarneri, L ; Scalisi, I ; Colletti, P ; Cartabellotta, F ; Savalli, F ; Cannizzaro, M ; Raimondo, G ; Craxì, A ; Di Marco, V

Journal of hepatology, 2017, Vol.66 (1), p.S735-S736 [Periódico revisado por pares]

Texto completo disponível